Most extremely successful value investors deploy a two-prong approach in selecting equities. The approach combines a top-down as well as a bottom-up approach. Such investors not only understand the fundamentals and nuances of their holdings, they also understand the economic dynamics of the industry in which their company's compete.
A value investor may be quite successful in employing a strictly bottom-up approach so long as he/she is extremely patient. That said, value recognition can generally be facilitated and return on investment enhanced, if the investor understands the micro or macro economics that affect the profits of their holdings. Additionally, such an understanding allows the investor to discern whether an earnings shortfall is terminal or temporary in nature.
One merely needs to turn the calendar back to 2008 to understand how a failure in comprehending the economic dynamics of housing-related stocks dealt many outstanding value minds a near fatal blow. In essence, when an investor does not fully appreciate the economics which may affect the profits of his holdings, he is not performing adequate risk assessment.
Top 5 Chemical Stocks To Buy Right Now: Trovagene Inc (TROV)
TrovaGene, Inc. (TrovaGene), incorporated on April 26, 2002, is a development-stage molecular diagnostic company that focuses on the development and marketing of urine-based nucleic acid tests for patient/disease screening and monitoring. The Company's novel tests predominantly use transrenal DNA (Tr-DNA) and transrenal RNA (Tr-RNA). The Company's technology is used to all transrenal nucleic acids (Tr-NA). The Company�� urine-based test addresses market needs, such as women�� healthcare-fetal medicine-down syndrome, infectious diseases, cancer testing, transplantation, drug development and monitoring of therapeutic outcomes, ultra-sensitive analytical and detection system, technologies for the collection, shipment and storage of urine specimens, and transrenal nucleic acid extraction, and instrumentation/system platform.
On January 18, 2011, the Company entered into an asset purchase agreement pursuant to which the Company acquired a hybridoma able to produce a monoclonal antibody targeting the NPM1 biomarker. On February 8, 2011, the Company entered into a sublicense agreement with MLL Munchner Leukamielabor (MLL). In July, 2011, the Company entered into a sublicense agreement with Fairview Health Services (Fairview) for NPM1 patent rights.
In October 2011, the Company entered into a license agreement pursuant to which the Company licensed the patent rights to a specific gene mutation with respect to chronic lymphoblastic leukemia. On December 12, 2011, the Company entered into a license agreement pursuant to which the Company licensed the patent rights to hairy cell leukemia biomarkers. On February 1, 2012, the Company acquired the clinical laboratory improvement amendments (CLIA) laboratory assets of MultiGEN Diagnostics, Inc. (MultiGEN).Advisors' Opinion:
- [By David Goodboy]
Fortunately, diagnostic issues may soon be a thing of the past. Several publicly traded companies are currently making great strides in the field of medical diagnostics, and my favorite company right now in that arena is TrovaGene (Nasdaq: TROV).
- [By Roberto Pedone]
TrovaGene (TROV) is a development stage molecular diagnostic company focused on the development and marketing of urine-based nucleic acid tests for patient/disease screening and monitoring. This stock closed up 6% to $10.02 in Friday's trading session.
Friday's Volume: 712,000
Three-Month Average Volume: 183,106
Volume % Change: 294%
From a technical perspective, TROV ripped higher here into all-time high territory with heavy upside volume. This stock has been uptrending strong for the last month and change, with shares soaring higher from its low of $5.75 to its new all-time high of $10.20. During that move, shares of TROV have been making mostly higher lows and higher highs, which is bullish technical price action. That move has also been accompanied by bullish upside volume flows.
Traders should now look for long-biased trades in TROV as long as it's trending above its recent breakout level of $8.83, and then once it sustains a move or close above its all-time high of $10.20 with volume that hits near or above 183,106 shares. If we get that move soon, then TROV will set up to enter new all-time high territory, which is bullish technical price action. Some possible upside targets off that move are $13 to $15.
Hot Performing Companies To Watch In Right Now: Plexus Corp.(PLXS)
Plexus Corp., together with its subsidiaries, provides electronic manufacturing services to original equipment manufacturers and other technology companies. The company offers product development and design services, including program management, feasibility studies, product conceptualization, specification development, circuit design, field programmable gate array design, printed circuit board layout, embedded software design, mechanical design, development of test specifications, and product verification testing. It also provides value-added services, such as engineering change-order management, cost reduction redesign, component obsolescence management, product feature expansion, test enhancement, and component re-sourcing. In addition, the company offers prototyping and new product introduction services comprising assembly of prototype products, materials management, analysis of the manufacturability and testability of a design, test implementation, and pilot productio n. Further, it provides test equipment development; material sourcing and procurement; agile manufacturing; fulfillment and logistic; after-market support; and regulatory requirements services. The company serves the wireline/networking, wireless infrastructure, medical, industrial/commercial, and defense/security/aerospace markets in the United States, Malaysia, China, the United Kingdom, Mexico, and Romania. Plexus Corp. was founded in 1979 and is headquartered in Neenah, Wisconsin.Advisors' Opinion:
- [By Seth Jayson]
Plexus (Nasdaq: PLXS ) reported earnings on July 17. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended June 29 (Q3), Plexus beat slightly on revenues and beat expectations on earnings per share.
Hot Performing Companies To Watch In Right Now: MediSwipe Inc (MWIP)
MediSwipe Inc., formerly Cannabis Medical Solutions Inc., incorporated in February 18, 1997, offers a transaction processing and security solutions for the medical and healthcare industries, using traditional, Internet Point-of-Sale (POS), e-commerce and mobile (wireless) payment solutions. The Company's electronic payment processing suite of services will enable clients to accept all credit cards, in store or online, debit and automated teller machine (ATM) cards and ACH check drafts for payment whether a retail, service, mail-order or Internet merchant. The Company�� card-based processing services enable merchants to process both traditional card-present, or swipe, transactions, as well as card-not-present transactions. The Company also operates online payment processing services, gift and loyalty card program programs and prepaid debit cards for consumers through 800 Commerce Inc., the Company's subsidiary, under the domain name www.800Commerce.com .
The Company offers MasterCard prepaid cards branded with corporations��brands. The Company offers a line of merchant services for the healthcare sector, including, Visa, MasterCard and merchant accounts, debit & credit card transaction processing, cash advance, gift/loyalty card programs and POS terminals through its��private banking network. 800 Commerce electronic payment processing and additional services enables the Company's clients to accept all credit cards, as well as debit and ATM cards for payment whether a retail, service, mail-order or Internet merchant. The 800 Commerce Suite of e-Commerce Services Include Merchant Processing Customized Solutions; Private Label Gateway; Credit Card Acceptance; Debit/ATM Card Acceptance; Private Label Debit Card Issuance; Internet Processing; Gift, Payroll and Loyalty Cards; Check Services; Wireless/Mobile Payment Platforms; Web Development and consulting, and ACH.
The Company competes with First Data Corporation, Total System Services, Global Payments, Authorize.net and Bank! of America's BA Merchant Services.Advisors' Opinion:
- [By Dan Burrows]
MediSwipe (MWIP) has tripled, with MWIP stock up 200%. Cannabis Science (CBIS) is closing in on quadrupling, as CBIS stock gained 273%. And GreenGro Technologies (GRNH)? Brace yourself, because GRNH stock is up over 1,000% … including an 18% so far today.
- [By Dan Burrows]
But it doesn’t end there. Investors should run away from all OTC marijuana stocks, including Medical Marijuana (MJNA), Cannabis Science (CBIS), CannaVest (CANV), MediSwipe (MWIP) and GreenGro Technologies (GRNH). As the SEC warns:
Hot Performing Companies To Watch In Right Now: Seanergy Maritime Holdings Corp (SHIP)
Seanergy Maritime Holdings Corp., through its subsidiaries, provides seaborne transportation of dry bulk commodities. As of May 7, 2013, the company�s fleet consisted of 7 drybulk carriers, including 2 Panamax, 2 Supramax, and 3 Handysize vessels with a total carrying capacity of approximately 326,255 dwt. Its fleet carries various dry bulk commodities, including coal, iron ore, and grains, as well as bauxite, phosphate, fertilizer, and steel products. Seanergy Maritime Holdings Corp. was founded in 2008 and is based in Athens, Greece.Advisors' Opinion:
- [By Roberto Pedone]
Another stock that looks poised to trigger a near-term breakout trade is Seanergy Maritime (SHIP), which provides transportation solutions in the dry bulk shipping sector through its vessel-owning subsidiaries for a range of dry bulk cargoes, including coal, iron ore, and grains, bauxite, phosphate and steel products. This stock has been red hot so far in 2013, with shares up a whopping 63%.
If you take a look at the chart for Seanergy Maritime, you'll notice that this stock has just started to spike back above both its 50-day and 200-day moving averages with above-average volume. In fact, volume for SHIP over the last few weeks has been showing bullish flows as the stock has flirted with those key moving averages. This move is quickly pushing shares of SHIP within range of triggering a near-term breakout trade.
Traders should now look for long-biased trades in SHIP if it manages to break out above some near-term overhead resistance at $1.74 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action 12,297 shares. If that breakout hits soon, then SHIP will set up to re-test or possibly take out its next major overhead resistance levels at $2.06 to $2.09 a share. Any high-volume move above those levels will then put $2.19 to its 52-week high at $2.71 into range for shares of SHIP.
Traders can look to buy SHIP off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day at $1.44 a share. One could also buy SHIP off strength once it takes out $1.74 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.